Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) — Cash Flow-to-Debt Ratio
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of TL-3.02 Million could theoretically repay 0% of its total liabilities (TL468.13 Million) in one year. See ANGEN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret across 7 annual periods. For the full cash flow conversion analysis, see Anatolia Tani ve Biyoteknoloji Urunleri cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)
Year-by-year debt coverage analysis for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret. Check earnings quality score of Anatolia Tani ve Biyoteknoloji Urunleri to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TRY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | TL141.41 Million | TL235.37 Million | ▼ -71.4% |
| 2023 | 2.10x | TL424.36 Million | TL201.96 Million | ▼ -72.6% |
| 2022 | 7.68x | TL311.02 Million | TL40.51 Million | ▼ -35.9% |
| 2021 | 11.98x | TL407.20 Million | TL33.98 Million | ▲ +204.0% |
| 2020 | 3.94x | TL235.47 Million | TL59.74 Million | ▲ +894.0% |
| 2019 | 0.40x | TL6.69 Million | TL16.86 Million | ▲ +28.5% |
| 2018 | 0.31x | TL3.16 Million | TL10.24 Million | — |